Takeda Announces FDA Accelerated Approval of ALUNBRIGTM (brigatinib)
Takeda Pharmaceutical Company Limited announced that ALUNBRIG™ (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration (FDA) for the treatment of...
Roche to present new data at AAN reinforcing efficacy and safety of newly FDA-approved OCREVUS
Roche announced that new data on OCREVUS™ in people with relapsing forms of multiple sclerosis (RMS) and primary progressive MS (PPMS) will be presented...
Medidata Wins Informa CARE Award for “Clinical Trial Partnership of the Year”
Medidata the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that its unique technology collaboration with...
Teva announces FDA approval of Austedo tablets for chorea associated with huntington’s disease
Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA has approved AUSTEDO™ (deutetrabenazine) tablets for the treatment of chorea associated with Huntington’s disease (HD)....
Ascendis Pharma A/S Showcases New Data on Rare Disease Product Pipeline at ENDO 2017
Ascendis Pharma A/S ,biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases announced data supporting its...
Intralytix and BioPhage partner to develop bacteriophage treatments of human wounds infected with S. aureus
Intralytix, Inc. announced that the Company is partnering with BioPhage Therapeutics Limited to develop and commercialize topical bacteriophage treatments of human wounds infected or...
Neurim Pharma Grants Exeltis Marketing Rights For Paediatric Prolonged-Release Melatonin in Spain
Neurim Pharmaceuticals and Exeltis announced a license agreement in which Exeltis will obtain exclusive marketing rights for Neurim’s new Rx PedPRM in Spain. Neurim’s...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...